[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Insulin Detemir Market Report 2018

March 2018 | 99 pages | ID: U9BB0D9A2E0QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Insulin Detemir market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Insulin Detemir in these regions, from 2013 to 2025 (forecast).
United States Insulin Detemir market competition by top manufacturers/players, with Insulin Detemir sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novo Nordisk
  • MNKD
  • Bristol-Myers Squibb Company
  • Emisphere
  • Biocon
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Resuable
  • Disposable
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Home Use
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Insulin Detemir Market Report 2018

1 INSULIN DETEMIR OVERVIEW

1.1 Product Overview and Scope of Insulin Detemir
1.2 Classification of Insulin Detemir by Product Category
  1.2.1 United States Insulin Detemir Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Insulin Detemir Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Resuable
  1.2.4 Disposable
1.3 United States Insulin Detemir Market by Application/End Users
  1.3.1 United States Insulin Detemir Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Use
  1.3.5 Others
1.4 United States Insulin Detemir Market by Region
  1.4.1 United States Insulin Detemir Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Insulin Detemir Status and Prospect (2013-2025)
  1.4.3 Southwest Insulin Detemir Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Insulin Detemir Status and Prospect (2013-2025)
  1.4.5 New England Insulin Detemir Status and Prospect (2013-2025)
  1.4.6 The South Insulin Detemir Status and Prospect (2013-2025)
  1.4.7 The Midwest Insulin Detemir Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Insulin Detemir (2013-2025)
  1.5.1 United States Insulin Detemir Sales and Growth Rate (2013-2025)
  1.5.2 United States Insulin Detemir Revenue and Growth Rate (2013-2025)

2 UNITED STATES INSULIN DETEMIR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Insulin Detemir Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Insulin Detemir Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Insulin Detemir Average Price by Players/Suppliers (2013-2018)
2.4 United States Insulin Detemir Market Competitive Situation and Trends
  2.4.1 United States Insulin Detemir Market Concentration Rate
  2.4.2 United States Insulin Detemir Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Insulin Detemir Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INSULIN DETEMIR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Insulin Detemir Sales and Market Share by Region (2013-2018)
3.2 United States Insulin Detemir Revenue and Market Share by Region (2013-2018)
3.3 United States Insulin Detemir Price by Region (2013-2018)

4 UNITED STATES INSULIN DETEMIR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Insulin Detemir Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Insulin Detemir Revenue and Market Share by Type (2013-2018)
4.3 United States Insulin Detemir Price by Type (2013-2018)
4.4 United States Insulin Detemir Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INSULIN DETEMIR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Insulin Detemir Sales and Market Share by Application (2013-2018)
5.2 United States Insulin Detemir Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INSULIN DETEMIR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insulin Detemir Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Insulin Detemir Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 MNKD
  6.2.2 Insulin Detemir Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 MNKD Insulin Detemir Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb Company
  6.3.2 Insulin Detemir Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Company Insulin Detemir Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Emisphere
  6.4.2 Insulin Detemir Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Emisphere Insulin Detemir Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biocon
  6.5.2 Insulin Detemir Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biocon Insulin Detemir Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 INSULIN DETEMIR MANUFACTURING COST ANALYSIS

7.1 Insulin Detemir Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin Detemir

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insulin Detemir Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin Detemir Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INSULIN DETEMIR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Insulin Detemir Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Insulin Detemir Sales Volume Forecast by Type (2018-2025)
11.3 United States Insulin Detemir Sales Volume Forecast by Application (2018-2025)
11.4 United States Insulin Detemir Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Insulin Detemir
Figure United States Insulin Detemir Market Size (K Pcs) by Type (2013-2025)
Figure United States Insulin Detemir Sales Volume Market Share by Type (Product Category) in 2017
Figure Resuable Product Picture
Figure Disposable Product Picture
Figure United States Insulin Detemir Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Insulin Detemir by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Insulin Detemir Market Size (Million USD) by Region (2013-2025)
Figure The West Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Insulin Detemir Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Insulin Detemir Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Insulin Detemir Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Insulin Detemir Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Insulin Detemir Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Insulin Detemir Sales Share by Players/Suppliers
Figure 2017 United States Insulin Detemir Sales Share by Players/Suppliers
Figure United States Insulin Detemir Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Insulin Detemir Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Insulin Detemir Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Insulin Detemir Revenue Share by Players/Suppliers
Figure 2017 United States Insulin Detemir Revenue Share by Players/Suppliers
Table United States Market Insulin Detemir Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Insulin Detemir Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Insulin Detemir Market Share of Top 3 Players/Suppliers
Figure United States Insulin Detemir Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Insulin Detemir Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Insulin Detemir Product Category
Table United States Insulin Detemir Sales (K Pcs) by Region (2013-2018)
Table United States Insulin Detemir Sales Share by Region (2013-2018)
Figure United States Insulin Detemir Sales Share by Region (2013-2018)
Figure United States Insulin Detemir Sales Market Share by Region in 2017
Table United States Insulin Detemir Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Insulin Detemir Revenue Share by Region (2013-2018)
Figure United States Insulin Detemir Revenue Market Share by Region (2013-2018)
Figure United States Insulin Detemir Revenue Market Share by Region in 2017
Table United States Insulin Detemir Price (USD/Pcs) by Region (2013-2018)
Table United States Insulin Detemir Sales (K Pcs) by Type (2013-2018)
Table United States Insulin Detemir Sales Share by Type (2013-2018)
Figure United States Insulin Detemir Sales Share by Type (2013-2018)
Figure United States Insulin Detemir Sales Market Share by Type in 2017
Table United States Insulin Detemir Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Insulin Detemir Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Insulin Detemir by Type (2013-2018)
Figure Revenue Market Share of Insulin Detemir by Type in 2017
Table United States Insulin Detemir Price (USD/Pcs) by Types (2013-2018)
Figure United States Insulin Detemir Sales Growth Rate by Type (2013-2018)
Table United States Insulin Detemir Sales (K Pcs) by Application (2013-2018)
Table United States Insulin Detemir Sales Market Share by Application (2013-2018)
Figure United States Insulin Detemir Sales Market Share by Application (2013-2018)
Figure United States Insulin Detemir Sales Market Share by Application in 2017
Table United States Insulin Detemir Sales Growth Rate by Application (2013-2018)
Figure United States Insulin Detemir Sales Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Insulin Detemir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk Insulin Detemir Sales Growth Rate (2013-2018)
Figure Novo Nordisk Insulin Detemir Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Insulin Detemir Revenue Market Share in United States (2013-2018)
Table MNKD Basic Information List
Table MNKD Insulin Detemir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MNKD Insulin Detemir Sales Growth Rate (2013-2018)
Figure MNKD Insulin Detemir Sales Market Share in United States (2013-2018)
Figure MNKD Insulin Detemir Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Insulin Detemir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Insulin Detemir Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Insulin Detemir Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Insulin Detemir Revenue Market Share in United States (2013-2018)
Table Emisphere Basic Information List
Table Emisphere Insulin Detemir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Emisphere Insulin Detemir Sales Growth Rate (2013-2018)
Figure Emisphere Insulin Detemir Sales Market Share in United States (2013-2018)
Figure Emisphere Insulin Detemir Revenue Market Share in United States (2013-2018)
Table Biocon Basic Information List
Table Biocon Insulin Detemir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biocon Insulin Detemir Sales Growth Rate (2013-2018)
Figure Biocon Insulin Detemir Sales Market Share in United States (2013-2018)
Figure Biocon Insulin Detemir Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin Detemir
Figure Manufacturing Process Analysis of Insulin Detemir
Figure Insulin Detemir Industrial Chain Analysis
Table Raw Materials Sources of Insulin Detemir Major Players/Suppliers in 2017
Table Major Buyers of Insulin Detemir
Table Distributors/Traders List
Figure United States Insulin Detemir Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Insulin Detemir Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Insulin Detemir Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Insulin Detemir Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Insulin Detemir Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Insulin Detemir Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Insulin Detemir Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Insulin Detemir Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Insulin Detemir Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Insulin Detemir Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Insulin Detemir Sales Volume Share Forecast by Region (2018-2025)
Figure United States Insulin Detemir Sales Volume Share Forecast by Region (2018-2025)
Figure United States Insulin Detemir Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications